|
[1]
|
World Health Organization. Global Cancer Observatory: Cancer Today. https://gco.iarc.fr/today/home. [2022-11-1].https://gco.iarc.fr/today/home |
|
[2]
|
He J, Wei WQ. China cancer registry annual report 2020. Beijing: People's Medical Publishing House. 2022. https://book.kongfz.com/575075/5231142426/. (In Chinese). https://book.kongfz.com/575075/5231142426/ |
|
[3]
|
Women and Children’s Health Division, Department of Health. Department of health and national women’s federation notice of issuance of management plan of rural women’s “two cancers” screening program. http://www.nhc.gov.cn/fys/s3581/200906/cd3c33a7ad624a50b8100b262041dabe.shtml. [2022-11-1]. (In Chinese). http://www.nhc.gov.cn/fys/s3581/200906/cd3c33a7ad624a50b8100b262041dabe.shtml |
|
[4]
|
Promotion Committee on Healthy China Initiative. Healthy China action plan (2019-2030). http://www.gov.cn/xinwen/2019-07/15/content_5409694.htm. [2022-11-1]. (In Chinese). http://www.gov.cn/xinwen/2019-07/15/content_5409694.htm |
|
[5]
|
World Health Organization. Global strategy to accelerate the elimination of cervical cancer as a public health problem. https://www.who.int/publications/i/item/9789240014107. [2022-6-28].https://www.who.int/publications/i/item/9789240014107 |
|
[6]
|
The State Council. China women’s development guidelines (2021-2030). http://www.gov.cn/zhengce/content/2021-09/27/content_5639412.htm. [2022-11-1]. (In Chinese). http://www.gov.cn/zhengce/content/2021-09/27/content_5639412.htm |
|
[7]
|
Wang LH. Promoting women’s life-cycle health and practicing high-quality development of whole-process services. Chin J Women Child Health 2021;12(5):1 − 4. http://dx.doi.org/10.19757/j.cnki.issn1674-7763.2021.05.001 (In Chinese). CrossRef
|
|
[8]
|
Sun KX, Zheng RS, Lei L, Zhang SW, Zeng HM, Wang SM, et al. Trends in incidence rates, mortality rates, and age-period-cohort effects of cervical cancer — China, 2003–2017. China CDC Wkly 2022;4(48):1070 − 6. http://dx.doi.org/10.46234/ccdcw2022.216CrossRef
|
|
[9]
|
Zhang M, Zhong YJ, Wang LM, Bao HL, Huang ZJ, Zhao ZP, et al. Cervical cancer screening coverage—China, 2018–2019. China CDC Wkly 2022;4(48):1077 − 82. http://dx.doi.org/10.46234/ccdcw2022.217CrossRef
|
|
[10]
|
Bao HL, Chen WH, Zhang XS, Bi H, Zhao Y, Cong S, et al. Prevalence of high-risk human papillomavirus in cervical intraepithelial neoplasia in the pre-vaccine era — China, 2017–2018. China CDC Wkly 2022;4(48):1083 − 7. http://dx.doi.org/10.46234/ccdcw2022.218CrossRef
|
|
[11]
|
Shao DT, Xia XY, Liu HH, Huang MX, Yu J, He JR, et al. Prevalence of high-risk human papillomavirus by subtypes among rural women aged 35–64 years — Guangzhou City, Guangdong Province, China, 2019–2021. China CDC Wkly 2022;4(48):1088 − 91. http://dx.doi.org/10.46234/ccdcw2022.219CrossRef
|